Immuron Joins International OTCQX

Published: Feb 10, 2009

NEW YORK, NY--(Marketwire - February 10, 2009) - Pink OTC Markets Inc., the leading electronic inter-dealer quotation system, trading technology and financial information provider for over-the-counter (OTC) securities, today announced that Immuron (PINKSHEETS: IMROY) (OTCQX: IMROY) (ASX: IMC), an Australian biotechnology company focused on oral immunotherapeutic products, has chosen to list its American Depositary Receipts (ADRs) on International OTCQX. Immuron's ADRs began trading today on the OTC market's prestigious tier, International PrimeQX. Investors can find current disclosure and financial information for the company on and

"As an OTCQX-listed company, Immuron distinguishes itself from the thousands of other companies traded over-the-counter and is associated with many of the most prestigious companies in our marketplace," said R. Cromwell Coulson, Chairman and CEO of Pink OTC Markets. "We welcome them to the International OTCQX market tier."

The Bank of New York Mellon will serve as Immuron's Principal American Liaison ("PAL") on the International OTCQX, responsible for providing guidance on listing requirements.

Immuron's ADRs will trade in the United States on International OTCQX under the ticker "IMROY" where each ADR will represent twenty ordinary shares. Immuron's shares are also listed on the Australian Securities Exchange (ASX). The company's headquarters are in Melbourne, Australia.

About Immuron

Immuron (PINKSHEETS: IMROY) (OTCQX: IMROY) (ASX: IMC) is an Australian biotechnology company with proprietary and proven commercial biotechnology for producing oral immunotherapeutic products. Their current commercial products and emerging research pipeline include products that contain antigen targeted antibodies and other proteins, to address a range gastrointestinal, infectious and immune-mediated diseases. Product pipeline includes solutions addressing Flu, HIV, Cancer related Mucositis, Diabetes and Metabolic Syndrome, and e.coli. For more about Immuron visit

For Investor relations inquiries, contact Dr. Oren Fuerst:

About International OTCQX

International OTCQX provides a gateway to U.S. securities markets for international companies that are listed on a qualified non-U.S. exchange and provide ongoing disclosure in English to U.S. investors. More importantly, International OTCQX distinguishes the reputable international issuers from the 8,000 over-the-counter (OTC) securities traded in the U.S. Only leading companies that have substantial operating businesses and provide credible disclosure to the public are eligible for inclusion on the premium-tier International OTCQX, which commenced trading on March 5, 2007. For more about International OTCQX, visit

About Pink OTC Markets Inc.

Pink OTC Markets Inc. provides the leading inter-dealer electronic quotation and trading system in the over-the-counter (OTC) securities market. We create innovative technology and data solutions to efficiently connect market participants, improve price discovery, increase issuer disclosure, and better inform investors. Pink OTC Markets operates the third largest U.S. equity trading venue which includes both the elite OTCQX market tiers for strong OTC-traded companies that can satisfy financial and disclosure listing standards and Pink Sheets for all other OTC quoted securities.

Over 230 financial service firms, including the ten largest U.S. investment banks, actively make markets in OTCQX and Pink Sheets quoted securities and in 2007 these firms traded over $160 billion of OTCQX and Pink Sheets securities. Pink OTC Markets offers widespread access to all U.S. broker-dealers, enabling investors to seamlessly trade these securities through their institutional, online, or full service brokers.

Pink OTC Markets is headquartered in New York City.

To learn more about how Pink OTC Markets' products and services make OTC markets more transparent, informed, and efficient, please visit our websites at, and or contact us at

Media Contact:
Chris Moore
CCG Investor Relations
+1 (646) 454-4519

Back to news